{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:11:50Z","timestamp":1793729510988,"version":"4.6.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche Medicale","doi-asserted-by":"publisher","award":["EQU202103012670"],"award-info":[{"award-number":["EQU202103012670"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["1 027 087 401"],"award-info":[{"award-number":["1 027 087 401"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["197 01GM1910A"],"award-info":[{"award-number":["197 01GM1910A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-18-CE17-0001"],"award-info":[{"award-number":["ANR-18-CE17-0001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0010"],"award-info":[{"award-number":["ANR-18-RHUS-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-14-CE14-0026-01"],"award-info":[{"award-number":["ANR-14-CE14-0026-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1160"],"award-info":[{"award-number":["SFB1160"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TPA08"],"award-info":[{"award-number":["TPA08"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390939984"],"award-info":[{"award-number":["390939984"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UG1CA233249"],"award-info":[{"award-number":["UG1CA233249"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["X01HD100702"],"award-info":[{"award-number":["X01HD100702"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01CA180886"],"award-info":[{"award-number":["U01CA180886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA264837"],"award-info":[{"award-number":["R01CA264837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA193776"],"award-info":[{"award-number":["R01CA193776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA140729"],"award-info":[{"award-number":["R01CA140729"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jaci.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T23:19:42Z","timestamp":1700176782000},"page":"67-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A\u00a0proposed approach to redefining ALPS and other lymphoproliferative immune disorders"],"prefix":"10.1016","volume":"153","author":[{"given":"Aude","family":"Magerus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rensing-Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Koneti","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-2721","authenticated-orcid":false,"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.11.004_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","article-title":"Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology","volume":"87","author":"Evans","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.jaci.2023.11.004_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-3476(67)80262-2","article-title":"Chronic lymphadenopathy simulating malignant lymphoma","volume":"70","author":"Canale","year":"1967","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2023.11.004_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/asheducation.V2012.1.301.3798316","article-title":"The many faces of common variable immunodeficiency","volume":"2012","author":"Cunningham-Rundles","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaci.2023.11.004_bib5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2023.11.004_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.11.004_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI115867","article-title":"A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease","volume":"90","author":"Sneller","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.11.004_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.11.004_bib9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0031-3955(05)70272-8","article-title":"Autoimmune lymphoproliferative syndrome. A\u00a0human disorder of abnormal lymphocyte survival","volume":"47","author":"Bleesing","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaci.2023.11.004_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-130-7-199904060-00020","article-title":"An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome","volume":"130","author":"Straus","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2023.11.004_bib11","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib12","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/bloodadvances.2021005835","article-title":"The contribution of rare copy number variants in FAS towards pathogenesis of autoimmune lymphoproliferative syndrome","volume":"6","author":"Jevtich","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2023.11.004_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clim.2017.06.009","article-title":"Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome","volume":"183","author":"Agrebi","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib14","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.11.004_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bj.2021.06.005","article-title":"The genetic landscape of the FAS pathway deficiencies","volume":"44","author":"Magerus","year":"2021","journal-title":"Biomed J"},{"key":"10.1016\/j.jaci.2023.11.004_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.11.004_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/clim.2002.5225","article-title":"A composite picture of TcR alpha\/beta(+) CD4(-)CD8(-) T cCells (alpha\/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome","volume":"104","author":"Bleesing","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.immuni.2015.04.010","article-title":"FAS Inactivation releases unconventional germinal center B cells that escape antigen control and drive ige and autoantibody production","volume":"42","author":"Butt","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.11.004_bib20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","article-title":"Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome","volume":"125","author":"Caminha","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib21","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-04-642488","article-title":"Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome","volume":"127","author":"Janda","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib22","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib23","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3324\/haematol.2012.081901","article-title":"Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia","volume":"98","author":"Rensing-Ehl","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2023.11.004_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2014-03-564286","article-title":"Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency","volume":"124","author":"Rensing-Ehl","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood-2015-11-685024","article-title":"Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome","volume":"128","author":"Volkl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib26","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.11.004_bib27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2023.11.004_bib28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2023.11.004_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.11.004_bib30","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1172\/JCI81746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"125","author":"Deau","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.11.004_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.11.004_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"Lopez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative disease in CVID: a report of types and frequencies from a US patient registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/pai.13535","article-title":"Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: a systematic review","volume":"32","author":"Hafezi","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib39","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1097\/HS9.0000000000000845","article-title":"Autoimmune lymphoproliferative syndrome (ALPS) disease and ALPS phenotype: are they two distinct entities?","volume":"7","author":"Palmisani","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaci.2023.11.004_bib40","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3324\/haematol.2016.153411","article-title":"Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome","volume":"102","author":"Klemann","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2023.11.004_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2023.11.004_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.11.004_bib44","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \"activated PI3Kdelta syndrome\"-targeted therapy with the PI3Kdelta inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2022018546","article-title":"A randomized, placebo-controlled phase 3 trial of the PI3Kdelta inhibitor leniolisib for activated PI3Kdelta syndrome","volume":"141","author":"Rao","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib46","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib47","doi-asserted-by":"crossref","unstructured":"Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, et\u00a0al. JAK-inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID and EBMT IEWP retrospective study [e-pub ahead of print]. J Allergy Clin Immunol https:\/\/doi.org\/10.1016\/j.jaci.2023.10.018. Accessed November 5, 2023.","DOI":"10.1016\/j.jaci.2023.10.018"},{"key":"10.1016\/j.jaci.2023.11.004_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","article-title":"Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome","volume":"139","author":"Nademi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40272-016-0175-3","article-title":"Optimal management of autoimmune lymphoproliferative syndrome in children","volume":"18","author":"George","year":"2016","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaci.2023.11.004_bib50","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib52","series-title":"GeneReviews","article-title":"Autoimmune lymphoproliferative syndrome","author":"Bleesing","year":"1993"},{"key":"10.1016\/j.jaci.2023.11.004_bib53","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1513\/AnnalsATS.201601-079OC","article-title":"Pulmonary manifestations of the autoimmune lymphoproliferative syndrome. a retrospective study of a unique patient cohort","volume":"13","author":"Lau","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2023.11.004_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1203\/00006450-200003000-00009","article-title":"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?","volume":"47","author":"van der Burg","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2023.11.004_bib55","unstructured":"Rensing-Ehl A, Lorenz MR, Fuehrer M, Willenbacher W, Willenbacher E, Sopper S, et\u00a0al. Abnormal biomarkers predict complex FAS or FADD gene defects missed by exome sequencing. J Allergy Clin Immunol, in press."},{"key":"10.1016\/j.jaci.2023.11.004_bib56","first-page":"218","article-title":"A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS","author":"Maccari","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2023.11.004_bib57","doi-asserted-by":"crossref","unstructured":"Pelle O, Moreno S, Lorenz MR, Riller Q, Fuehrer M, Stolzenberg MC, et\u00a0al. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome [e-pub ahead of print]. J Allergy Clin Immunol https:\/\/doi.org\/10.1016\/j.jaci.2023.09.028. Accessed October 2, 2023.","DOI":"10.1016\/j.jaci.2023.09.028"},{"key":"10.1016\/j.jaci.2023.11.004_bib58","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.96.8.4552","article-title":"Defective\u00a0CD95\/APO-1\/Fas signal complex formation in the human autoimmune\u00a0lymphoproliferative syndrome, type Ia","volume":"96","author":"Martin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2023.11.004_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2013.02.019","article-title":"Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation","volume":"147","author":"Hauck","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1150179","article-title":"Case report: neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous FAS variant effectively treated with sirolimus","volume":"11","author":"Elgharbawy","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2023.11.004_bib61","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10875-012-9731-y","article-title":"A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect","volume":"32","author":"Simesen de Bielke","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108757","article-title":"Complete CD95\/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS)","volume":"228","author":"Tessarin","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib63","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","article-title":"A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib64","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","volume":"131","author":"Magerus-Chatinet","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2014.10.006","article-title":"A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome","volume":"155","author":"Nabhani","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/pr.2015.170","article-title":"Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation","volume":"78","author":"Ruiz-Garcia","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2023.11.004_bib67","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2015.08.025","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly","volume":"137","author":"Sobh","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib68","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jaci.2022.11.028","article-title":"Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations","volume":"151","author":"Maccari","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2350-8-41","article-title":"Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) type Ib","volume":"8","author":"Bi","year":"2007","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jaci.2023.11.004_bib70","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.11.004_bib71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ajhg.2010.10.028","article-title":"Whole-exome-sequencing-based discovery of human FADD deficiency","volume":"87","author":"Bolze","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2023.11.004_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2015.02.002","article-title":"A new case of Fas-associated death domain protein deficiency and update on treatment outcomes","volume":"136","author":"Savic","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.gastro.2018.09.041","article-title":"Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency","volume":"156","author":"Lehle","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2023.11.004_bib74","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10875-015-0150-8","article-title":"Caspase-8 deficiency presenting as late-onset multi-organ lymphocytic infiltration with granulomas in two adult siblings","volume":"35","author":"Niemela","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib75","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.11.004_bib76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjh.16098","article-title":"FAS-mediated apoptosis impairment in patients with ALPS\/ALPS-like phenotype carrying variants on CASP10 gene","volume":"187","author":"Miano","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2023.11.004_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human\u00a0caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2023.11.004_bib78","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00439-006-0138-9","article-title":"Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome","volume":"119","author":"Zhu","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2023.11.004_bib79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","article-title":"The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions","volume":"38","author":"Rieux-Laucat","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib80","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni0503-404","article-title":"The death effector domain protein family: regulators of cellular homeostasis","volume":"4","author":"Tibbetts","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656356","article-title":"Next generation sequencing for detecting somatic FAS mutations in patients with autoimmune lymphoproliferative syndrome","volume":"12","author":"Lopez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib82","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib83","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1038\/s41467-023-39295-7","article-title":"NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells","volume":"14","author":"Delage","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2023.11.004_bib84","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2015-06-654145","article-title":"Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome","volume":"126","author":"Rensing-Ehl","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.11.004_bib85","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3389\/fimmu.2019.01193","article-title":"Paradoxical CD4 lymphopenia in autoimmune lymphoproliferative syndrome (ALPS)","volume":"10","author":"Lisco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.11.004_bib86","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923014343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923014343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:05:08Z","timestamp":1777475108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923014343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0091674923014343"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.11.004","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A\u00a0proposed approach to redefining ALPS and other lymphoproliferative immune disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}